CATALYST trial: Oxford leads part of major COVID-19 drugs trial
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death. In some patients, COVID-19 can progress to severe respiratory failure requiring admission to an intensive care unit and mechanical […]
